A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
S Iriguchi, Y Yasui, Y Kawai, S Arima… - Nature …, 2021 - nature.com
Clinical successes demonstrated by chimeric antigen receptor T-cell immunotherapy have
facilitated further development of T-cell immunotherapy against wide variety of diseases …
facilitated further development of T-cell immunotherapy against wide variety of diseases …
Adoptive immunotherapy: a human pluripotent stem cell perspective
The past decade has witnessed significant advances in cancer immunotherapy, particularly
through the adoptive transfer of engineered T cells in treating advanced leukemias and …
through the adoptive transfer of engineered T cells in treating advanced leukemias and …